I disagree that there is nothing new.
No safety issues - positive
1 partial response very early in trial - positive, especially when these patients having no alternative available other than death!
progression to next stage of the trial - positive
The flip side is safety issues, efficacy issues no further trial.
Yes they have to report but both companies will be happy on progress I would suggest. My glass is half full.
Merry Xmas
I disagree that there is nothing new. No safety issues -...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
29.5¢ |
Change
0.005(1.72%) |
Mkt cap ! $428.5M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 30.5¢ | 28.5¢ | $469.8K | 1.579M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 297652 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 7500 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMM (ASX) Chart |